ホーム / ニュース / Certara Recognized by NJBIZ as One of New Jersey’s Best Places to Work

Certara Recognized by NJBIZ as One of New Jersey’s Best Places to Work

Princeton, N.J., 2021 年 6 月 29 日: Certara, the global leader in biosimulation, today announced that it has been recognized as one of the “Best Places to Work” in New Jersey in 2021 by NJBIZ, one of New Jersey’s leading business journals. Certara is headquartered in Princeton, N.J.

“We are honored to be named one of the best places to work in New Jersey in a year where we continue to grow rapidly while dealing with the challenges of the COVID-19 pandemic,” said Certara’s CEO William Feehery, Ph.D. “As a mission-driven company, our people and culture of teamwork, innovation, and passion are critical to our success.  I would like to thank our dedicated team who is responsible for this distinction and contribute to our thriving work environment.”

Certara’s mission is to accelerate medicines to patients using biosimulation and technology.  The Certara team includes approximately 1,000 scientists and experts worldwide who transform drug development by partnering with biopharmaceutical companies, including the top 35 leading, global companies. 

NJBIZ’s survey and recognition program are dedicated to identifying and recognizing the best employers in the state. The NJBIZ honorees are decided based upon their participation with the Best Places to Work survey, from fellow BridgeTower Media firm Best Companies Group. The program confidentially collects data, allowing workers to comfortably share feedback about their employers, and for those companies to learn from and act on what they learn. Certara and the other winners’ rankings will be revealed at an upcoming award event on 2021 年 9 月 9 日. For additional information or to register for the event follow this link: https://njbiz.com/event/best-places-work-2021/.


Certara(サターラ) について

サターラは、バイオシミュレーションソフトウェアと技術を用いて、従来の創薬・開発を変革し、医薬品をよりスピーディーに患者さんに届けることをミッションとしています。バイオ医薬品企業1,650社以上、主要学術機関、主要な規制当局がサターラのソフトウェアやコンサルティングサービスを利用しております。弊社のお客様は61か国以上に広がっております。

投資家の皆様:

David Deuchler
Gilmartin Group
ir@certara.com

※英語または日本語でお問合せください

衣斐桃果
m-ebi@prap.co.jp
ariane.lovell@finnpartners.com 

※英語または日本語でお問合せください

トップに戻る
Powered by Translations.com GlobalLink OneLink Software